Mission Bay seals the deal on $7.5M bioscience fund
Mission Bay Capital, a San Francisco-based venture capital firm focusing on seed-stage investments in biotech companies spun out of the California Institute for Quantitative Biosciences and the University of California, announced that it closed its new fund, its first, at $7.5 millon.
Counting Wilson Sonsini Goodrich & Rosati, John Wadsworth Jr. of Manitou Ventures, and Pfizer among its limited partners, the firm says it will be giving 20 percent of the profit it makes on its portfolio companies back to the University in order to endow the Institute for Quantitative Biosciences, also known as QB3.
Next Story: Vdopia raises $4M Series A for high-clickthrough App Store ads
Previous Story: RingCube boxes $211K to virtualize operating systems
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.